News

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
New Delhi: Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment ...
French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
U2 rock star Bono has been a prominent activist in the global fight against HIV/AIDS, including working with the George W.
The World Health Organization (WHO) has issued new guidelines recommending the twice-yearly use of injectable lenacapavir ...
We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...
There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...